A Biofourmis team member will be in contact soon to schedule your demo. In the meantime, stay up-to-date with the latest Biofourmis news by following us on LinkedIn and Twitter.
What Our Customers Are Saying
“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital therapeutics, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology.”
Satoko ShisaiChugai’s Vice President, Head of Digital & IT Supervisory Division
"The Everion® biosensor has become part of my daily habit. I wear it and forget about it and I know a care team is always there to make sure I am safe."
Congestive Heart Failure Patient
"The goal of this program is to leverage Biovitals® to remotely monitor patients and identify COVID-19 related physiological biomarkers that indicate deterioration in patients."
Prof. David Chung Wah Siu, MDDepartment of Medicine, The University of Hong Kong
Forbes partnered with venture firms Sequoia Capital and Meritech Capital to create our second annual AI 50, a list of private, U.S.-based companies that are using artificial intelligence in meaningful business-oriented ways.